Ann: Converting Note & Non-Renounceable Entitlement Offer, page-29

@skorpian. I can tell you with authority that there is more to that transaction than meets the eye and there was more to that transaction that met the Board's eye at the time.

Let me ask you this. Would you have paid $400k for a business that was losing money?

Yes I am angry about it and it cost meb so much more than the initial purchase price. It is still paying the price in terms of legacy costs. In addition, it deflected a lot of time, money and resources from our core business of pursuing fda. If meb had focussed on fda, as Jack assured me it would, meb would still have millions in the bank.

The previous management cost this company millions of dollars, so yes I am angry. Don't get me started and there are people on here wanting the return of previous management. Please, give me a break!